Skip to content
10-Q

Quarterly Report

Bellerophon Therapeutics, Inc.

0001558370-23-019044

← back to feed
Filed
Nov 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 10, 2023 12.23M sh
Shares Diluted Q3 2023 · Sep 30, 2023 12.23M sh
Shares Diluted Q3 2023 · Sep 30, 2023 11.61M sh
Shares Diluted Q3 2023 · Sep 30, 2022 9.55M sh
Shares Diluted Q3 2023 · Sep 30, 2022 9.55M sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$7.99M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$13.42M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $4.38M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $6.92M
Stockholders Equity Q3 2023 · Sep 30, 2023 $3.72M
Stockholders Equity Q3 2023 · Jun 30, 2023 $5.62M
Stockholders Equity Q3 2023 · Dec 31, 2022 $2.53M
Stockholders Equity Q3 2023 · Sep 30, 2022 $7.43M
Stockholders Equity Q3 2023 · Jun 30, 2022 $12.28M
Stockholders Equity Q3 2023 · Dec 31, 2021 $21.62M
Current Liabilities Q3 2023 · Sep 30, 2023 $1.26M
Current Liabilities Q3 2023 · Dec 31, 2022 $5.4M
Total Liabilities Q3 2023 · Sep 30, 2023 $1.26M
Total Liabilities Q3 2023 · Dec 31, 2022 $5.4M
Current Assets Q3 2023 · Sep 30, 2023 $4.98M
Current Assets Q3 2023 · Dec 31, 2022 $7.56M
Total Assets Q3 2023 · Sep 30, 2023 $4.98M
Total Assets Q3 2023 · Dec 31, 2022 $7.94M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.16
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.36
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.53
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.55
Eps Basic Q3 2023 · Sep 30, 2023 −$0.16
Eps Basic Q3 2023 · Sep 30, 2023 −$0.36
Eps Basic Q3 2023 · Sep 30, 2022 −$0.53
Eps Basic Q3 2023 · Sep 30, 2022 −$1.55
Sga Expense Q3 2023 · Sep 30, 2023 $1.63M
Sga Expense Q3 2023 · Sep 30, 2023 $5.6M
Sga Expense Q3 2023 · Sep 30, 2022 $1.37M
Sga Expense Q3 2023 · Sep 30, 2022 $4.65M
Net Income Q3 2023 · Sep 30, 2023 −$1.92M
Net Income Q3 2023 · Sep 30, 2023 −$4.24M
Net Income Q3 2023 · Sep 30, 2022 −$5.07M
Net Income Q3 2023 · Sep 30, 2022 −$14.82M
Operating Income Q3 2023 · Sep 30, 2023 −$2.17M
Operating Income Q3 2023 · Sep 30, 2023 −$5.95M
Operating Income Q3 2023 · Sep 30, 2022 −$5.12M
Operating Income Q3 2023 · Sep 30, 2022 −$17.3M
Revenue Q3 2023 · Sep 30, 2023 $5.64M